Genie Energy Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Genie Energy Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $102.90M | Mar 14, 2025 |
| FY2024 | Sep 30, 2024 | $111.92M | Mar 14, 2025 |
| FY2024 | Jun 30, 2024 | $90.70M | Mar 14, 2025 |
| FY2024 | Mar 31, 2024 | $119.69M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $104.93M | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | $125.05M | Mar 14, 2025 |
| FY2024 | Jun 30, 2023 | $93.46M | Mar 14, 2025 |
| FY2024 | Mar 31, 2023 | $105.26M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $81.39M | Mar 14, 2025 |
| FY2024 | Sep 30, 2022 | $81.29M | Mar 14, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $138.48M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $146.21M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $154.78M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $91.64M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $95.05M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $82.90M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $76.55M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $85.51M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $76.94M | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $66.65M | Mar 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.59M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $19.54M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $87.81M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $29.21M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $13.16M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $4.18M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $22.79M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | ($6.99M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($24.53M) | Mar 16, 2018 |
| FY2015 | Dec 31, 2015 | ($3.79M) | Mar 15, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($20.80M) | Mar 14, 2025 |
| FY2024 | Sep 30, 2024 | $11.68M | Mar 14, 2025 |
| FY2024 | Jun 30, 2024 | $10.56M | Mar 14, 2025 |
| FY2024 | Mar 31, 2024 | $9.85M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | ($34.18M) | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | $17.89M | Mar 14, 2025 |
| FY2024 | Jun 30, 2023 | $15.04M | Mar 14, 2025 |
| FY2024 | Mar 31, 2023 | $11.26M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $15.48M | Mar 14, 2025 |
| FY2024 | Sep 30, 2022 | $23.54M | Mar 14, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $207.0K | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | $39.0K | Mar 16, 2020 |
| FY2017 | Dec 31, 2016 | ($269.0K) | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $1.99M | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | $5.54M | Mar 16, 2017 |
| FY2015 | Dec 31, 2013 | $7.36M | Mar 15, 2016 |
| FY2014 | Dec 31, 2012 | $9.37M | Mar 16, 2015 |
| FY2013 | Dec 31, 2011 | $2.65M | Mar 17, 2014 |
| FY2013 | Jul 31, 2011 | $7.84M | Mar 17, 2014 |
| FY2013 | Dec 31, 2010 | $3.05M | Mar 17, 2014 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $93.40M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $91.11M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $74.96M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $67.55M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $71.78M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $72.67M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $61.54M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $80.12M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $61.57M | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $66.01M | Mar 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $70.74M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $62.48M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $80.68M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $68.38M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $23.12M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $15.75M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $19.37M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $9.38M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $15.55M | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | ($3.08M) | Mar 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $584.0K | Mar 19, 2019 |
| FY2018 | Dec 31, 2017 | $3.29M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $586.0K | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $324.0K | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | $1.44M | Mar 16, 2017 |
| FY2015 | Dec 31, 2013 | $313.0K | Mar 15, 2016 |
| FY2014 | Dec 31, 2012 | $91.0K | Mar 16, 2015 |
| FY2013 | Dec 31, 2011 | $134.0K | Mar 17, 2014 |
| FY2013 | Jul 31, 2011 | $151.0K | Mar 17, 2014 |
| FY2013 | Dec 31, 2010 | $45.0K | Mar 17, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $371.28M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $330.56M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $277.62M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $229.47M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $187.34M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $156.24M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $146.86M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $125.78M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $121.81M | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $155.82M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $191.72M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $146.05M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $103.97M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $118.68M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $101.26M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $75.31M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $54.20M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $58.65M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $41.95M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $41.12M | Mar 16, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $190.51M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $197.24M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $187.12M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $123.29M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $98.10M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $94.81M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $103.67M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $84.01M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $96.53M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $123.38M | Mar 16, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.75M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $10.00M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $10.00M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $10.00M | Mar 15, 2023 |
| FY2022 | Dec 31, 2020 | $10.00M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $12.14M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $11.08M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $10.00M | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $8.73M | Mar 19, 2019 |
| FY2017 | Dec 31, 2015 | $3.66M | Mar 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $64.57M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $60.20M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $49.01M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($29.12M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($56.66M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($59.67M) | Mar 16, 2021 |
| FY2019 | Jan 31, 2019 | $300.0K | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | ($53.94M) | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | ($67.47M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($51.57M) | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $104.46M | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | $107.61M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $98.57M | Mar 14, 2025 |
| FY2022 | Dec 31, 2021 | $93.57M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $31.90M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $31.24M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $41.60M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $29.91M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $35.19M | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $38.79M | Mar 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $863.0K | Mar 16, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Mar 14, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 14, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Mar 14, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Mar 14, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $4.21M | Mar 21, 2013 |